{rfName}
A

Indexed in

License and use

Citations

8

Altmetrics

Analysis of institutional authors

Muñoz-Sanchez, CAuthorRey-Salido, MAuthor
Share
Publications
>
Editorial Material

A Pilot Experience Using a 1-Bag Intravenous Rapid Desensitization Protocol for Chemotherapy and Biologics in a Cohort of Patients With Access to a Delabeling Pathway

Publicated to:Journal Of Investigational Allergology And Clinical Immunology. 33 (4): 289-291 - 2023-01-01 33(4), DOI: 10.18176/jiaci.0860

Authors: Vázquez-Revuelt, P; Lleonart-Bellfill, R; Molina-Mata, K; Muñoz-Sánchez, C; Rey-Salido, M; Madrigal-Burgaleta, R

Affiliations

Catalan Inst Oncol, Inst Catala Oncol ICO, Drug Desensitisat Ctr, Barcelona, Spain - Author
Catalan Inst Oncol, Inst Catala Oncol ICO, Med Oncol Dept, Barcelona, Spain - Author
Catalan Inst Oncol, Inst Catala Oncol ICO, Pharm Dept, Barcelona, Spain - Author
Hosp Univ Bellvitge, Allergy Dept, Barcelona, Spain - Author
Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain - Author
St Bartholomews Hosp, Allergy & Severe Asthma Serv, Barts Hlth NHS Trust, 4th Floor, King George V Bldg, London EC1A 7BE, England - Author
St Bartholomews Hosp, Allergy & Severe Asthma Serv, Barts Hlth NHS Trust, London, England - Author
See more

Abstract

Keywords
Administration, intravenousAgedAllergyAntiemetic agentBeta adrenergic receptor blocking agentBiological markerBiological productBiological productsClinical protocolCognitive defectDelabelingDesensitizationDesensitization, immunologicDipeptidyl carboxypeptidase inhibitorDrug allergyDrug challengeDrug hypersensitivityEpinephrineFolinate calciumForced expiratory volumeHumanHumansImmunoglobulin eIntracutaneous testIntravenous drug administrationNoteOne bag intravenous rapid desensitization protocolOxaliplatinPersonalized medicinePrick testProceduresPruritusRisk assessmentSkin tinglingThroat tightnessVignette

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Journal Of Investigational Allergology And Clinical Immunology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2023, it was in position 5/39, thus managing to position itself as a Q1 (Primer Cuartil), in the category Allergy.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 5.54, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-11, the following number of citations:

  • WoS: 3
  • Scopus: 5
  • OpenCitations: 3
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-11:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 7 (PlumX).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: United Kingdom.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Vázquez-Revuelt, P) and Last Author (Madrigal-Burgaleta, R).

the author responsible for correspondence tasks has been Madrigal-Burgaleta, R.